Description
Clerimed film-coated tablets are an antibiotic belonging to the group of so-called macrolide antibiotics. Macrolide antibiotics are drugs that suppress or stop the growth of certain microorganisms (bacteria) that cause various infections.
Clerimed is indicated for the treatment of infections caused by susceptible microorganisms. This includes:
Lower respiratory tract infections such as bronchitis and pneumonia
Upper respiratory tract infections such as sinusitis and pharyngitis
Skin and soft tissue infections such as folliculitis, cellulite and erysipelas
Common or localized mycobacterial infections caused by certain types of microorganisms (Mycobacterium avium or Mycobacterium intracellulare; localized infections caused by Mycobacterium chelonae, Mycobacterium fortuitum or Mycobacterium kandadii).
Prevention of common infections caused by Mycobacterium avium complex in AIDS patients with CD4 lymphocyte counts equal to or less than 100 / mm3.
Eradication of Helicobacter pylori in patients with duodenal ulcer in combination with other medicinal products that suppress gastric acidity.
Treatment of odontogenic (dental) infections.
As with other antibiotics, before prescribing Clerimed film-coated tablets, your doctor will consider the resistance of the micro-organism to an antibiotic and the related recommendations for prescribing antibiotics.
The usual dose of Clerimed for adults and children over 12 years of age is one 250 mg tablet twice a day. In more severe infections, the dose may be increased to 500 mg twice a day. The usual duration of treatment is 5 to 14 days, except for the treatment of community-acquired pneumonia and sinusitis, which require 6 to 14 days of treatment.
Patients with renal impairment
In patients with renal impairment with creatinine clearance <30 ml / min, the dose of Clerimed should be halved, ie. 250 mg once daily or 250 mg twice daily for more severe infections. In these patients, treatment should not last more than 14 days.
Patients with mycobacterial infections
The recommended dose of Clerimed film-coated tablets for adults with mycobacterial infections is 500 mg twice daily. Treatment of common mycobacterial infections in AIDS patients should be continued for as long as clinically and microbiologically. Clerimed film-coated tablets should be used in combination with other antimicrobials.
Treatment of other non-tuberculous mycobacterial infections should be continued at the discretion of the physician.
Prevention of Mycobacterium avium complex infections
The recommended dose of Clerimed in adults is 500 mg twice daily.
Odontogenic (dental) infections
The dose of Clerimed for the treatment of these infections is one 250 mg tablet twice a day for 5 days.
In patients with peptic ulcer due to Helicobacter pylori, Clerimed is administered at a dose of 500 mg twice daily in combination with other appropriate antimicrobial drugs and proton pump inhibitors for 7 to 17 days.
Pediatric population
Clerimed has not been studied in children under 12 years of age.
